Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Raedle

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cancer|July 15, 2005
BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumorsNikolaus Lubomierski, Guido Plotz, Marc Wormek, et al.
Gastroenterology|January 10, 2002
Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression systemJoerg Trojan, Stefan Zeuzem, Ann Randolph, et al.
European Journal of Gastroenterology & Hepatology|September 17, 2008
Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver diseaseTanja M Raedle-Hurst, Christoph Welsch, Nicole Forestier, et al.
International Journal of Colorectal Disease|September 16, 2005
Screening colonoscopy in 40- to 50-year-old first-degree relatives of patients with colorectal cancer is efficient: a controlled multicentre studyMarkus Menges, Johannes Fischinger, Barbara Gärtner, et al.
European Journal of Pediatrics|March 28, 2007
Hypothesis: Possible role of retinoic acid therapy in patients with biallelic mismatch repair gene defectsSven Gottschling, Harald Reinhard, Constanze Pagenstecher, et al.
Nucleic Acids Research|December 1, 2006
Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repairGuido Plotz, Christoph Welsch, Luis Giron-Monzon, et al.
International Journal of Clinical Oncology|March 28, 2013
Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patientsThomas Thomaidis, Arndt Weinmann, Martin Sprinzl, et al.
BMC Cancer|December 13, 2006
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancerHelmut Friess, Jan M Langrehr, Helmut Oettle, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer|July 15, 2005
BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumorsNikolaus Lubomierski, Guido Plotz, Marc Wormek, et al.
Gastroenterology|January 10, 2002
Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression systemJoerg Trojan, Stefan Zeuzem, Ann Randolph, et al.
European Journal of Gastroenterology & Hepatology|September 17, 2008
Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver diseaseTanja M Raedle-Hurst, Christoph Welsch, Nicole Forestier, et al.
International Journal of Colorectal Disease|September 16, 2005
Screening colonoscopy in 40- to 50-year-old first-degree relatives of patients with colorectal cancer is efficient: a controlled multicentre studyMarkus Menges, Johannes Fischinger, Barbara Gärtner, et al.
European Journal of Pediatrics|March 28, 2007
Hypothesis: Possible role of retinoic acid therapy in patients with biallelic mismatch repair gene defectsSven Gottschling, Harald Reinhard, Constanze Pagenstecher, et al.
Nucleic Acids Research|December 1, 2006
Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repairGuido Plotz, Christoph Welsch, Luis Giron-Monzon, et al.
International Journal of Clinical Oncology|March 28, 2013
Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patientsThomas Thomaidis, Arndt Weinmann, Martin Sprinzl, et al.
BMC Cancer|December 13, 2006
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancerHelmut Friess, Jan M Langrehr, Helmut Oettle, et al.
Pageof 3